glycopeptide,neutral_mass,mass_accuracy,ms1_score,ms2_score,q_value,total_signal,start_time,end_time,apex_time,charge_states,msms_count,peptide_start,peptide_end,protein_name,mass_shifts
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.103500622312,-4.2787523139134096e-06,8.97992283361,15.0280866395,0,21885694.5,86.2532068914,86.3483532733,86.31677562259,3,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4},3999.799287123383,-4.0989299278705445e-06,11.2749451168,23.1067888128,0,16971361.0,75.6119354592,75.8163930243,75.769476726278,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:3; Hex:5; HexNAc:4},4291.93326601,-8.05142654565e-06,0,14.6065957175,0,0,,,,3,1,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,
GTAGNALMDGASQLMGEN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:1},3805.548254496893,-5.146623451831368e-06,8.03375603908,19.3005587275,0,21442922.75,72.8143815226,73.146376374,73.052695574983,3;4,1,376,395,sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2,Unmodified
N(N-Glycosylation)LTVPGSLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3015.2918488515597,-3.925629230351342e-06,10.358652247,70.0976102509,0,74423494.0,52.2406982567,52.5523619559,52.381134806697,3,2,1118,1127,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:5; HexNAc:5},3083.35995075043,-6.49418136391803e-06,14.8116708649,20.9475578124,0,199949293.25,34.1539218094,34.489078123,34.304999075953,3;4,3,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)TTSYVLR{Fuc:1; Hex:5; HexNAc:4},2721.14977340681,-4.579874747026981e-06,8.76806670969,18.5928541161,0,28172152.6875,35.7735387232,35.9733224895,35.865877142175,2;3,1,1033,1041,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:4},2795.1037076663283,-4.394952457153675e-06,17.1676087064,79.4537543293,0,679373964.875,25.9212820596,26.5250311242,26.157473574702,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:5},2836.1265189843275,-3.0134639059413597e-06,14.7678742594,64.0172560141,0,190928854.625,26.3492093907,26.9102952586,26.510767275715,3,2,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0496192037417,-4.18499664471673e-06,17.8280018028,55.7036424283,0,1571569826.0,26.0534391072,26.9247573084,26.305123542372,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:9; HexNAc:4},3605.3743376630664,-5.2136755814372155e-06,12.5904797484,15.4370812992,0,425209682.375,60.1637165414,61.2476088749,60.384160342439,3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:6; HexNAc:2},2487.082887460372,-7.852317544575018e-06,17.7029184055,121.361058174,0,671666890.5,53.2525084085,53.831509259,53.50259843928,2;3,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:7; HexNAc:2},2649.1320165165894,-5.9774304225600905e-06,16.9612528058,61.7477085251,0,357363756.625,52.972207525,53.4570249425,53.190520440165,2;3,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:4; HexNAc:2},2162.971132240273,-6.204882392190794e-06,13.6041995678,25.4362634523,0,86249641.75,53.9885016428,54.3260679231,54.20342185758,2,2,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
LKISYKDAIN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6868972781526,-5.431756254707657e-06,12.1090730606,12.0765913728,0,100178728.25,49.6854801403,50.0271925595,49.808684574191,3;4,3,2780,2791,sp|P15924|DESP_HUMAN Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.162385664699,-8.51469644552933e-06,13.9649495843,46.8762923142,0,239514576,96.0726912763,96.1341570403,96.088024074459,4,2,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:3; Hex:5; HexNAc:4},5023.39484851982,-9.659616972841601e-06,-21.1585394118,27.2668586026,0,17438512,96.2572041895,96.2572041895,96.257204189523,4,1,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:4; HexNAc:4},4569.208484038585,-6.740906087595555e-06,-20.9240934569,24.8328803891,0,50826082,96.0726912763,96.0880240745,96.072691276296,4,2,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
N(N-Glycosylation)MSFVNDLTVTQDGRK{Hex:7; HexNAc:2},3364.443317953567,-9.27705858822042e-06,9.85915142065,17.6931746612,0,13121985.625,59.7095491912,59.8668623076,59.77263242267,3,2,195,211,sp|Q9HDC9|APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2,Unmodified
AEPPLN(N-Glycosylation)ASASDQGEK{Hex:6; HexNAc:2},2891.2006331463276,-6.6865627123429085e-06,11.6565751849,29.5183547195,0,43532154.875,30.8595752424,31.3676130917,31.098036506399,3,2,925,940,sp|Q9Y4L1|HYOU1_HUMAN Hypoxia up-regulated protein 1 OS=Homo sapiens OX=9606 GN=HYOU1 PE=1 SV=1,Unmodified
ALPQPQN(N-Glycosylation)VTSLLGC(Carbamidomethyl)TH{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3940.66230637,7.20455595742e-07,0,9.26749212264,0.00990099009901,0,,,,3,2,446,462,sp|P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens OX=9606 GN=HPX PE=1 SV=2,
FEDGVLDPDYPRN(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},6380.796922761822,-8.34543539425178e-06,11.6020869989,40.9499815847,0,58846648,95.3698176927,95.4330084588,95.401480005805,4,3,229,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
N(N-Glycosylation)GSLFAFR{Hex:5; HexNAc:4; Neu5Ac:2},3115.2490637204187,-3.377796004091189e-06,11.4007658172,16.5524093433,0,202780723.25,70.918687223,72.1052620079,71.476975157483,3,3,168,176,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
N(N-Glycosylation)GSLFAFR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3116.27295742,-4.49745060597e-06,0,16.0024103366,0,0,,,,3,2,168,176,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,
N(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Hex:5; HexNAc:4; Neu5Ac:2},4976.10746020007,-4.005941449199525e-06,10.560539089,15.4709988839,0,137275243.0,90.5662837253,90.9310470249,90.676597005749,4,2,241,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
N(N-Glycosylation)ISDGFDGIPDNVDAALALPAHSYSGR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},4977.110480403251,-5.12969706483632e-07,-6.30314478557,15.0134401106,0,17543173,90.4708877232,90.7246606058,90.582033259296,4,1,241,268,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,Unmodified
GHVN(N-Glycosylation)ITR{Hex:5; HexNAc:4; Neu5Ac:2},3000.2154226469092,-2.6156046595895854e-06,14.4836704648,45.6447370041,0,382732833.0,26.5107672757,27.1753568596,26.703589390341,3,1,117,124,sp|P00734|THRB_HUMAN Prothrombin OS=Homo sapiens OX=9606 GN=F2 PE=1 SV=2,Unmodified
HFDEN(N-Glycosylation)LTGR{Fuc:1; Hex:9; HexNAc:5},3707.420764406404,3.800203772702575e-06,8.47506293546,19.7825655109,0,19926931.875,53.3786568072,53.5648225413,53.44137420915,3,2,2281,2290,"sp|P02549|SPTA1_HUMAN Spectrin alpha chain, erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTA1 PE=1 SV=5",Unmodified
N(N-Glycosylation)ITRIK{Fuc:1; Hex:6; HexNAc:3},2471.090606640072,-4.9642803300880496e-06,12.7438960375,38.9251952542,0,54485200.78125,53.1433147417,53.5335130559,53.394189590836,2,2,150,156,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,Unmodified
N(N-Glycosylation)ITRIK{Hex:6; HexNAc:3},2325.0326489679805,-5.255114738369367e-06,16.3724859238,35.2140981092,0,427328744.625,53.5648225413,54.1260833568,53.800024575615,2;3,1,150,156,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3017.305559038558,-7.0030795041069245e-06,11.3345350372,69.2833947977,0,52751899.125,41.3588837729,41.662931723,41.542310089493,3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.162385664699,-8.51469644552933e-06,13.9649495843,46.8762923142,0,239514576,96.0726912763,96.1341570403,96.088024074459,4,2,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:3; Hex:5; HexNAc:4},5023.39484851982,-9.659616972841601e-06,-21.1585394118,27.2668586026,0,17438512,96.2572041895,96.2572041895,96.257204189523,4,1,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:4; HexNAc:4},4569.208484038585,-6.740906087595555e-06,-20.9240934569,24.8328803891,0,50826082,96.0726912763,96.0880240745,96.072691276296,4,2,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
EFAN(N-Glycosylation)FTFPR{Hex:8; HexNAc:2},2831.15282324,-0.00036433807559,0,9.45295197983,0.015625,0,,,,3,1,209,218,sp|Q96L92|SNX27_HUMAN Sorting nexin-27 OS=Homo sapiens OX=9606 GN=SNX27 PE=1 SV=2,
VLPVN(N-Glycosylation)VTDYC(Carbamidomethyl)QLVR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3734.63865742,-7.33619178823e-06,0,26.4991764994,0,0,,,,3,1,443,457,sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4,
VLPVN(N-Glycosylation)VTDYC(Carbamidomethyl)QLVR{Fuc:3; Hex:5; HexNAc:4},3735.63571537,-1.08546024002e-06,0,21.0410166083,0,0,,,,3,1,443,457,sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4,
VLPVN(N-Glycosylation)VTDYC(Carbamidomethyl)QLVR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},4026.72161521,1.35638441188e-06,0,15.0035528325,0,0,,,,3,1,443,457,sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4,
VLPVN(N-Glycosylation)VTDYC(Carbamidomethyl)QLVR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4025.7362221,-7.33932810058e-06,0,11.2808728508,0,0,,,,3,1,443,457,sp|P35555|FBN1_HUMAN Fibrillin-1 OS=Homo sapiens OX=9606 GN=FBN1 PE=1 SV=4,
AVFNETKN(N-Glycosylation)STR{Fuc:1; Hex:7; HexNAc:5},3561.4579654138274,8.377342992170097e-07,13.9265192946,15.6889203901,0,143149183.625,28.4378240254,28.9845172908,28.644002805773,3,2,688,699,sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,Unmodified
AVFN(N-Glycosylation)ETKNSTR{Fuc:1; Hex:7; HexNAc:5},3561.4579654138274,8.377342992170097e-07,13.9265192946,15.6889203901,0,143149183.625,28.4378240254,28.9845172908,28.644002805773,3,2,688,699,sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,Unmodified
APVVN(N-Glycosylation)C(Carbamidomethyl)SIAVC(Carbamidomethyl)QR{Fuc:2; Hex:5; HexNAc:8},4199.74269049,-1.18385382561e-06,0,6.36527590821,0.0398406374502,0,,,,3,1,1016,1029,sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,
TVIN(N-Glycosylation)FTMPNTIKHYVHRVGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4733.09485517,2.06676187343e-06,0,17.189073447,0,0,,,,4,1,533,553,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=2,
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:2; Hex:6; HexNAc:4},4459.003149804909,-5.3218281448245265e-06,-4.81561121593,34.4403606916,0,16535920.75,81.720918356,81.8638238416,81.769000942135,4,3,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4441.9776618616315,-3.052202686424122e-06,14.7155059341,31.2776828447,0,510749736.5,81.546646391,81.9434433725,81.769000942135,3;4,3,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},4734.09016101982,-2.1629027147114932e-06,-21.6926920563,11.550084662,0,3171994.25,84.9372635073,84.9372635073,84.937263507271,4,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
LGLSFNSISAVDN(N-Glycosylation)GSLANTPHLR{Fuc:1; Hex:5; HexNAc:5},4353.958580410327,-2.4162728270225055e-06,-21.0048234804,10.0672309533,0.00990099009901,2487484.5,79.1723297582,79.1723297582,79.172329758231,3,1,249,272,sp|P07585|PGS2_HUMAN Decorin OS=Homo sapiens OX=9606 GN=DCN PE=1 SV=1,Unmodified
YSM(Oxidation)KEDGC(Carbamidomethyl)N(N-Glycosylation)SSDK{Hex:5; HexNAc:3; Neu5Ac:1},3246.1672193356935,5.315583807276428e-06,12.9874651919,6.40552247395,0.0398406374502,299176863.5,24.3805197901,25.7882178929,24.970705992603,3,2,1114,1127,sp|P46100|ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens OX=9606 GN=ATRX PE=1 SV=6,Unmodified
TKTEISEMNRN(N-Glycosylation)ISR{Fuc:2; Hex:5; HexNAc:4},3592.549891363471,-1.5724706662346388e-06,-3.76828818267,6.56232292331,0.0276497695853,16194816,71.649440156,71.7287263737,71.649440156047,5,3,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",Unmodified
EVN(N-Glycosylation)DTLLVNELK{Fuc:1; Hex:5; HexNAc:4},3154.40137315,-6.862530198e-06,0,13.2838978676,0,0,,,,3,1,596,608,sp|Q15063|POSTN_HUMAN Periostin OS=Homo sapiens OX=9606 GN=POSTN PE=1 SV=2,
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:4},2795.1037076663283,-4.394952457153675e-06,17.1676087064,79.4537543293,0,679373964.875,25.9212820596,26.5250311242,26.157473574702,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:5},2836.1265189843275,-3.0134639059413597e-06,14.7678742594,64.0172560141,0,190928854.625,26.3492093907,26.9102952586,26.510767275715,3,2,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0496192037417,-4.18499664471673e-06,17.8280018028,55.7036424283,0,1571569826.0,26.0534391072,26.9247573084,26.305123542372,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:9; HexNAc:4},3605.3743376630664,-5.2136755814372155e-06,12.5904797484,15.4370812992,0,425209682.375,60.1637165414,61.2476088749,60.384160342439,3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:2},2963.3804661401296,-8.884265181442237e-07,10.8223950439,98.3796825764,0,79178491.75,76.228614623,76.3831453588,76.321801609421,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:2},2947.3949043733464,-4.0666349082651604e-06,14.3572511572,89.4916910779,0,141916527.25,84.5908915586,84.9686972922,84.747949873034,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:6; HexNAc:2},3109.457176814051,-6.893486545008539e-06,12.4785062394,30.3059148661,0,37786161.125,84.32061924,84.5276536252,84.479755292956,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:3; HexNAc:2},2639.2889251747715,-6.3420936114802215e-06,10.8387304151,28.9455369454,0,31334754.625,77.0877051737,77.3371808913,77.119038858636,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:4; Neu5Ac:1},3644.6609187933723,-6.54076032677797e-06,-20.2746027142,18.8539621618,0,6598385.5,87.1875972734,87.3459901081,87.187597273413,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:4; HexNAc:2},2801.3369888931798,-4.276142923003044e-06,8.27953669358,17.7850634825,0,12442290.5,76.7434207227,76.8379468427,76.775442292913,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Fuc:2; Hex:5; HexNAc:4},3645.6647830520615,-2.0029325941990123e-06,11.5175508415,16.70918615,0,13736828.0,87.1394193079,87.2986735251,87.250792291387,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVKR{Fuc:1; Hex:5; HexNAc:4},3655.7317765781327,-8.505362026797311e-06,-20.8203900358,13.5410670439,0,3943422.25,80.2353420244,80.2511403905,80.25114039046,3,1,190,207,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:4; HexNAc:5},3394.5833994006525,-4.47385275174012e-06,-21.4446420939,11.9368519359,0,1727535.75,84.32061924,84.32061924,84.32061924003,3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Fuc:3; Hex:5; HexNAc:4},3791.7316339262193,-4.284083792633125e-06,13.4211262316,11.4199868285,0,37394461.0,42.2916513747,42.6019498096,42.555382806683,3;4,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:3; HexNAc:2},2623.2940854244775,-6.409448041248844e-06,11.5085731598,9.95919370509,0.00990099009901,36202629.875,85.6188226726,85.8089849061,85.681935273234,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:3; Neu5Ac:1},3441.56122681,-1.02261419689e-06,0,6.7145342568,0.0325203252033,0,,,,3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,
WHRRVN(N-Glycosylation)TTQK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3222.3966876196278,-1.0328376857517046e-06,14.0981296982,51.9451409809,0,50111074.625,29.7145320918,29.8929107891,29.80325594209,3,2,110,120,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,Unmodified
RVN(N-Glycosylation)TTQKR{Hex:7; HexNAc:5},3151.34570074,-1.91939320041e-06,0,14.8065866567,0,0,,,,3,1,113,121,sp|P36578|RL4_HUMAN Large ribosomal subunit protein uL4 OS=Homo sapiens OX=9606 GN=RPL4 PE=1 SV=5,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3636.5698415631427,-1.813596383457684e-06,6.7043356633,26.1245524146,0,28139205.375,85.9525427566,86.4911928084,86.285354755942,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:2; Hex:6; HexNAc:4},3653.598879600539,-5.560981653657534e-06,11.6674200172,19.9397735485,0,107631925.0,86.1114006426,86.5226015594,86.253206891441,3,4,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3991.785038842874,-7.439974028112925e-06,12.9031046631,19.336093273,0,154379250.875,65.3993271576,65.9054278757,65.636114242299,3;4,3,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},4001.70673921,-2.82304006432e-06,0,17.173977293,0,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3700.7036793544125,-1.1823641883899728e-05,8.41546445075,15.1125432976,0,7751311.875,62.1082681404,62.4231893724,62.375987456862,3,2,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3637.59058285,-1.90660957907e-06,0,12.412395864,0,0,,,,3,2,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3992.76354787,-0.00025250876786,0,11.1877470173,0,0,,,,3,1,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Hex:6; HexNAc:4; Neu5Ac:1},3652.5628750602164,-1.2906410069364793e-06,13.924614245,9.16735422458,0.00990099009901,329906208.75,53.2525084085,53.8936245746,53.50259843928,3;4,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
HN(N-Glycosylation)STGC(Carbamidomethyl)LR{Hex:5; HexNAc:4; Neu5Ac:2},3148.2143731590795,-3.981499394237928e-06,16.014036577,44.35561496,0,104228528.6875,23.4292345749,23.7814083404,23.591640773042,3,2,289,297,sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:5; HexNAc:2},2789.2937002847575,-7.055806419911588e-06,12.9302498613,110.564020586,0,102504370.75,64.3328114416,64.5985531396,64.44251554273,2;3,2,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:6; HexNAc:2},2951.34403608851,-5.825515914115673e-06,13.7266223189,97.379208637,0,172417866.75,63.9866516418,64.3169128921,64.127819191043,2;3,2,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
QVVEN(N-Glycosylation)M(Oxidation)TR{Hex:3; HexNAc:2},1883.802718485111,-5.214580818134591e-06,12.7377357403,15.0030394646,0,29620730.625,23.4438287761,23.6785844074,23.606410891438,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
VVN(N-Glycosylation)STTGPGEHLR{Hex:5; HexNAc:4; Neu5Ac:1},3279.393616279439,-5.036319305218942e-06,13.2075183282,14.6074894589,0,62176024.75,29.7883113251,30.0692808575,29.907658241812,3,2,1064,1077,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,Unmodified
VFPYISVMVNN(N-Glycosylation)GSLSYDHSK{Fuc:1; Hex:3; HexNAc:4},3700.649536749458,-7.340166540787223e-06,-3.58188071349,13.4003309921,0,6308297.0,79.7433346735,79.791583342,79.79158334198,3,1,172,192,sp|Q12907|LMAN2_HUMAN Vesicular integral-membrane protein VIP36 OS=Homo sapiens OX=9606 GN=LMAN2 PE=1 SV=1,Unmodified
DEDEN(N-Glycosylation)STGNK{Hex:7; HexNAc:7},3663.3802367225176,-6.34380220320539e-06,11.8112921786,11.49792211,0,88449121.75,61.7804078923,62.1862056083,61.968096707884,3,3,393,403,sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,Unmodified
DLQNVN(N-Glycosylation)ITLR{Fuc:1; Hex:6; HexNAc:4},3115.346474516047,-8.98679042528433e-07,16.9972797101,57.4650571958,0,459603566.75,24.5139165745,24.8679848061,24.61671684049,3;4,4,83,93,sp|P35232|PHB1_HUMAN Prohibitin 1 OS=Homo sapiens OX=9606 GN=PHB1 PE=1 SV=1,Unmodified
DLQNVN(N-Glycosylation)ITLR{Fuc:1; Hex:7; HexNAc:4},3277.4014383837607,-1.5073361909803114e-06,14.1081731234,52.5595207048,0,182146856.5,24.4258511093,24.64606339,24.529215692107,3;4,2,83,93,sp|P35232|PHB1_HUMAN Prohibitin 1 OS=Homo sapiens OX=9606 GN=PHB1 PE=1 SV=1,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3017.305559038558,-7.0030795041069245e-06,11.3345350372,69.2833947977,0,52751899.125,41.3588837729,41.662931723,41.542310089493,3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:3; HexNAc:4},4407.162385664699,-8.51469644552933e-06,13.9649495843,46.8762923142,0,239514576,96.0726912763,96.1341570403,96.088024074459,4,2,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:3; Hex:5; HexNAc:4},5023.39484851982,-9.659616972841601e-06,-21.1585394118,27.2668586026,0,17438512,96.2572041895,96.2572041895,96.257204189523,4,1,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:4; HexNAc:4},4569.208484038585,-6.740906087595555e-06,-20.9240934569,24.8328803891,0,50826082,96.0726912763,96.0880240745,96.072691276296,4,2,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
IQMLSFAGEPLPQN(N-Glycosylation)SSMAR{Hex:5; HexNAc:4},3698.6346491168297,-1.0763655304481123e-05,13.8421574068,6.79770298099,0.0144230769231,117097642.25,46.8831672257,47.1157817747,46.975910042349,3;4,3,604,623,sp|Q16853|AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens OX=9606 GN=AOC3 PE=1 SV=3,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9091682810135,-4.052122623944089e-06,17.0490723036,103.705608102,0,836952329.25,27.826790391,28.5117896225,28.037096475188,2;3,3,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9091682810135,-4.052122623944089e-06,17.0490723036,103.705608102,0,836952329.25,27.826790391,28.5117896225,28.037096475188,2;3,3,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8036834599448,-4.875041001683166e-06,14.6819958244,80.010920848,0,76186686.0,28.5271720078,28.7614793764,28.599620356782,2,1,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8036834599448,-4.875041001683166e-06,14.6819958244,80.010920848,0,76186686.0,28.5271720078,28.7614793764,28.599620356782,2,1,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:1},2814.1676048166164,-4.567235307785123e-06,12.9489507685,79.0957498827,0,126485166.0625,29.2664419757,30.0106396065,29.490571724002,3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:1},2814.1676048166164,-4.567235307785123e-06,12.9489507685,79.0957498827,0,126485166.0625,29.2664419757,30.0106396065,29.490571724002,3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0736506472595,-5.673755403888713e-06,11.3656962356,65.4875779231,0,99368651.625,27.8422237263,28.378582806,28.274936623001,3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0736506472595,-5.673755403888713e-06,11.3656962356,65.4875779231,0,99368651.625,27.8422237263,28.378582806,28.274936623001,3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3460381928826,-2.725084866902185e-06,11.9639427699,65.2270478222,0,154616674.25,70.981995458,71.4465259896,71.217261539523,3,5,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3460381928826,-2.725084866902185e-06,11.9639427699,65.2270478222,0,154616674.25,70.981995458,71.4465259896,71.217261539523,3,5,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:6; HexNAc:5},3489.4850065371907,1.4664920696572721e-06,-21.7589568553,58.6084560407,0,2704180.25,70.3955373393,70.3955373393,70.395537339274,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:6; HexNAc:5},3489.4850065371907,1.4664920696572721e-06,-21.7589568553,58.6084560407,0,2704180.25,70.3955373393,70.3955373393,70.395537339274,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:1},3179.3038642221495,-5.320797851376603e-06,11.9341455368,46.4471142643,0,94788571.625,28.7465148078,29.4297750062,29.119472673162,3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:1},3179.3038642221495,-5.320797851376603e-06,11.9341455368,46.4471142643,0,94788571.625,28.7465148078,29.4297750062,29.119472673162,3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:3},2482.044470671445,-4.70758203311095e-06,11.9458603766,46.0990927858,0,67812164.375,27.6930034226,27.9019428915,27.811225309594,2;3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:3},2482.044470671445,-4.70758203311095e-06,11.9458603766,46.0990927858,0,67812164.375,27.6930034226,27.9019428915,27.811225309594,2;3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3488.494965648231,-7.236043224765823e-06,13.9489550276,44.4853473609,0,179232099.125,70.3644061075,70.9510809726,70.616548556709,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3488.494965648231,-7.236043224765823e-06,13.9489550276,44.4853473609,0,179232099.125,70.3644061075,70.9510809726,70.616548556709,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:4; Hex:6; HexNAc:5},3635.53483594,3.62991942729e-06,0,18.4682445304,0,0,,,,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:4; Hex:6; HexNAc:5},3635.53483594,3.62991942729e-06,0,18.4682445304,0,0,,,,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:7; HexNAc:6},3854.63896516,-4.31827274886e-06,0,11.1310522705,0.00847457627119,0,,,,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:7; HexNAc:6},3854.63896516,-4.31827274886e-06,0,11.1310522705,0.00847457627119,0,,,,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
N(N-Glycosylation)DTASYK{Hex:5; HexNAc:2},2013.7724237227546,2.9724120286880547e-06,15.6646057452,9.76113464058,0.015625,139492365.375,27.7520461585,28.2142194575,27.948590356731,2,2,207,214,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
N(N-Glycosylation)LTKLK{Fuc:1; Hex:4; HexNAc:7},2931.2966523176865,-4.3044543637999114e-06,14.4821540837,56.1976536165,0,48498449.0,28.1700886752,28.3352849231,28.214219457531,3,2,1023,1029,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
N(N-Glycosylation)LTKLK{Hex:9; HexNAc:4},2986.268081781493,-5.343244814734603e-06,15.6958160149,35.5165080458,0,511630684.875,43.307578908,44.2657086915,43.571224239095,3,1,1023,1029,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
LRRGN(N-Glycosylation)ETSFVPSR{Hex:3; HexNAc:2},2410.155700533806,-1.3365238680814842e-05,-21.1650866383,6.32202284758,0.04296875,4494257.75,90.1223259237,90.201977943,90.201977943007,2,1,1927,1940,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
LN(N-Glycosylation)GTDPIVAADSK{Hex:7; HexNAc:3},3043.2824141795622,-2.4603783819417698e-06,10.4368322339,8.9731844194,0.00990099009901,17311720.625,40.8868439899,41.0230122592,40.931964376195,3,1,4073,4086,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,Unmodified
GVTHLN(N-Glycosylation)ISGLKM(Oxidation)PR{Fuc:1; Hex:8; HexNAc:3},3590.564618230989,-0.00028021291678760135,-4.47264097564,6.86666661004,0.0325203252033,12540558.75,76.1333849893,76.2759511894,76.275951189423,3,1,3947,3961,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,Unmodified
LN(N-Glycosylation)GTDPIVAADSKR{Fuc:4; Hex:6; HexNAc:5},4027.70488132,2.16328498408e-06,0,6.40436168933,0.0398406374502,0,,,,3,1,4073,4087,sp|Q07954|LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens OX=9606 GN=LRP1 PE=1 SV=2,
ILQDKLN(N-Glycosylation)STMK{Fuc:2; Hex:4; HexNAc:4},3042.32891602,5.59036504897e-06,0,6.57072576863,0.0325203252033,0,,,,3,1,2623,2634,"sp|Q14573|ITPR3_HUMAN Inositol 1,4,5-trisphosphate receptor type 3 OS=Homo sapiens OX=9606 GN=ITPR3 PE=1 SV=2",
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3058.3360653089712,-4.529982900967827e-06,10.7667663892,17.2777003182,0,40370325.375,41.8170529908,42.1551744408,42.016959924126,3,2,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3220.3876446992635,-3.915734149102602e-06,15.5851869507,14.4877390701,0,190798116.25,41.2826663242,41.7408166594,41.496295939509,3,2,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
ALVN(N-Glycosylation)FTR{Hex:5; HexNAc:4; Neu5Ac:1},2733.1565277402906,-7.031012829249565e-06,-6.19138189172,75.169233167,0,5078414.625,52.1476827727,52.3191690908,52.240698256715,3,1,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,Unmodified
ALVN(N-Glycosylation)FTR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3025.26928759,-5.34137909534e-06,0,59.2792873593,0,0,,,,3,1,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3384.443678870879,3.446775722266591e-07,11.8957227979,53.7086093771,0,112301224.875,29.207355025,29.7590950396,29.32564513944,3,2,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3472.468918916433,-2.31233653927005e-06,12.6816818449,10.4476805857,0.015625,60275195.25,30.934639826,31.3528147247,31.068602906291,3,1,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
ITNLRVN(N-Glycosylation)LTR{Fuc:2; Hex:8; HexNAc:4},3599.5367828266567,9.366925156565594e-06,12.8118955761,6.03281205183,0.05,96570373.25,54.4185644732,54.6511739558,54.511212840303,3,1,241,251,sp|P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2,Unmodified
TAN(N-Glycosylation)DTSTEAYNLLLR{Hex:5; HexNAc:2},2897.2678164024965,-4.513123247708143e-06,5.68195903875,32.339778305,0,15721587.75,69.0117418752,69.2154438561,69.183863058313,3,2,1202,1217,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,Unmodified
LLNN(N-Glycosylation)LTSIK{Fuc:1; Hex:7; HexNAc:4},3107.3770180791557,-7.887652947581009e-06,13.2472297064,11.6547582302,0.00847457627119,39203178.625,43.4311230725,43.6798375593,43.508500423654,3,2,646,655,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,Unmodified
GSTRFN(N-Glycosylation)K{Hex:7; HexNAc:2},2348.9335663806105,5.99985320628693e-06,13.9102742758,35.3107371604,0,119141081.0,28.1117599593,28.6587219741,28.408261540159,2,2,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
GSTRFN(N-Glycosylation)K{Hex:6; HexNAc:2},2186.8790060282213,7.238713451839605e-06,13.6263812702,8.68026390848,0.0229007633588,118238042.125,28.4378240254,29.0293459918,28.791507540766,2,2,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
GSTRFN(N-Glycosylation)K{Hex:5; HexNAc:2},2024.8256115486226,8.100081055717006e-06,15.5759915613,7.63420079017,0.0367647058824,206172814.125,28.6734173562,29.3109291897,29.029345991834,2,1,2939,2946,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
ASNVTN(N-Glycosylation)KTDPR{Fuc:2; Hex:6; HexNAc:6; Neu5Ac:1},3975.61743514,-1.99010401766e-06,0,11.9117636456,0,0,,,,3,1,1,12,sp|P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,
ASNVTN(N-Glycosylation)KTDPR{Hex:5; HexNAc:4},2824.208083084377,-7.564031458926621e-06,14.0699795553,10.5920039007,0,147287639.0,43.7111605233,44.2502682235,44.003557859484,3,1,1,12,sp|P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,Unmodified
ASNVTN(N-Glycosylation)KTDPR{Fuc:2; Hex:5; HexNAc:4},3116.27868211,7.65534029966e-06,0,7.1734157765,0.0304347826087,0,,,,3,1,1,12,sp|P07910|HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens OX=9606 GN=HNRNPC PE=1 SV=4,
RTPAKM(Oxidation)C(Carbamidomethyl)LN(N-Glycosylation)R{Fuc:6; Hex:8; HexNAc:7},4855.960076949564,8.065946639697115e-07,13.5405100043,65.465084696,0,57171382.0,72.3729966229,72.5464369085,72.451707039897,4,2,333,343,sp|Q13510|ASAH1_HUMAN Acid ceramidase OS=Homo sapiens OX=9606 GN=ASAH1 PE=1 SV=5,Unmodified
TVLEN(N-Glycosylation)STSYEEAK{Hex:5; HexNAc:2},2686.134212770799,-8.481439118125246e-06,11.1876829605,13.7234798437,0,27558450.25,36.3783880578,36.6994131591,36.486482324823,2;3,2,254,267,sp|Q13510|ASAH1_HUMAN Acid ceramidase OS=Homo sapiens OX=9606 GN=ASAH1 PE=1 SV=5,Unmodified
QVEELQVN(N-Glycosylation)HTALRELR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},3790.7339920384175,-1.1886818389859852e-05,10.3735784276,8.14222305166,0.0188679245283,78723510.25,42.3696440763,42.9856117751,42.400663259252,3;4,1,431,447,sp|Q9H8L6|MMRN2_HUMAN Multimerin-2 OS=Homo sapiens OX=9606 GN=MMRN2 PE=1 SV=2,Unmodified
LLLKIKN(N-Glycosylation)GTPPM(Oxidation)R{Fuc:1; Hex:4; HexNAc:5},3305.5518501741058,1.5337169840588629e-06,13.5897175526,16.3445100316,0,39363451.75,50.2461123572,50.3550415065,50.292779940987,3,1,499,512,sp|O75533|SF3B1_HUMAN Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3,Unmodified
LLLKIKN(N-Glycosylation)GTPPM(Oxidation)R{Fuc:1; Hex:4; HexNAc:4},3102.4753643888216,7.036467762538862e-07,12.2185892082,7.26932065223,0.0304347826087,57356204.25,50.4320516573,50.6048470404,50.541412825012,3,1,499,512,sp|O75533|SF3B1_HUMAN Splicing factor 3B subunit 1 OS=Homo sapiens OX=9606 GN=SF3B1 PE=1 SV=3,Unmodified
LLEN(N-Glycosylation)MTEVVR{Fuc:2; Hex:8; HexNAc:5},3806.554783259216,3.5183442762933232e-06,-5.7000828647,17.4157425412,0,7183007.0,72.9092398232,73.0369331068,72.97312224172,3;4,1,604,614,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,Unmodified
AVPVPN(N-Glycosylation)MTPSGVGRER{Fuc:2; Hex:5; HexNAc:6},3986.731944606635,-3.4367101513232508e-06,-5.25447514404,5.84525289594,0.0144230769231,10954324.0,89.1669792241,89.2456764088,89.229926942412,3,4,406,422,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,Unmodified
VN(N-Glycosylation)KTSK{Fuc:1; Hex:8; HexNAc:8},3742.5217300814475,-3.931798123999132e-06,11.644213733,63.0966309979,0,65325308.625,44.9548301246,45.3403055058,45.122832622751,3;4;5,1,1053,1059,sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,Unmodified
LIVEN(N-Glycosylation)LSSR{Hex:5; HexNAc:4; Neu5Ac:1},2943.2621869730638,-1.1227021291819216e-06,11.1500360502,7.55356532226,0.043795620438,124802146.125,39.4629241731,40.1266899095,39.896339792633,3,1,109,118,sp|Q13243|SRSF5_HUMAN Serine/arginine-rich splicing factor 5 OS=Homo sapiens OX=9606 GN=SRSF5 PE=1 SV=1,Unmodified
N(N-Glycosylation)HSIFLADINQER{Hex:6; HexNAc:2},2934.28058632034,-1.0427316321692064e-05,12.8398372546,81.7259821515,0,14562302.125,55.4344180093,55.5605580078,55.513123657926,3,2,196,209,sp|P50897|PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,Unmodified
LVLIN(N-Glycosylation)K{Fuc:4; Hex:7; HexNAc:6},3635.53628728,2.86283646408e-06,0,38.4598362234,0,0,,,,3,1,804,810,sp|O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,
LVLIN(N-Glycosylation)K{Fuc:3; Hex:8; HexNAc:7},3854.61771571,8.47465341819e-07,0,34.672224806,0,0,,,,3,1,804,810,sp|O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,
LVLIN(N-Glycosylation)K{Fuc:3; Hex:6; HexNAc:6},3327.4387637330533,-8.417059342931577e-07,14.0880573934,34.5892419948,0,202153890.0,45.0601841396,45.5423813568,45.230527991676,3;4,1,804,810,sp|O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,Unmodified
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4003.8464256319376,-5.2449282529585185e-06,13.7728064443,25.0019252421,0,130735153.125,66.882736006,67.1820560402,67.039854425812,3;4,2,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4498.031180455602,-6.884275293077617e-06,-4.0429272526,10.478903636,0.00574712643678,8637994.75,69.0117418752,69.0595839924,69.059583992386,4,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Hex:4; HexNAc:5},3810.79618230496,-4.765472694410686e-06,-5.10461937328,6.87110335845,0.0325203252033,6958645.5,64.7246442066,64.7875926759,64.771929008389,3,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
DVSGKMN(N-Glycosylation)R{Fuc:1; Hex:7; HexNAc:4},2998.1864764800594,-8.049987911661812e-07,13.7236179666,61.7998171987,0,61584453.25,26.2610061234,26.4225327756,26.378054092948,3,2,295,303,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,Unmodified
EQYIHEN(N-Glycosylation)YSR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3397.3493514125903,-4.23589114391912e-06,10.5126358258,10.748473455,0,9987913.375,62.6126157588,62.9464581754,62.946458175405,3,2,541,551,sp|O60568|PLOD3_HUMAN Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Homo sapiens OX=9606 GN=PLOD3 PE=1 SV=1,Unmodified
FLRSAEFFN(N-Glycosylation)YTVR{Fuc:2; Hex:6; HexNAc:5},3928.67794498,-3.09218378046e-06,0,8.04435904922,0.0276497695853,0,,,,3,1,54,67,sp|O60568|PLOD3_HUMAN Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Homo sapiens OX=9606 GN=PLOD3 PE=1 SV=1,
LEIC(Carbamidomethyl)N(N-Glycosylation)LTPDALK{Fuc:3; Hex:5; HexNAc:4},3446.49092206,-3.81154246064e-06,0,14.4540618153,0,0,,,,3,2,347,359,sp|P07384|CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens OX=9606 GN=CAPN1 PE=1 SV=1,
YPSLANRN(N-Glycosylation)GTK{Fuc:1; Hex:5; HexNAc:4},2988.2906769537058,-6.768633423655704e-06,13.2761718616,15.2058054547,0,52787563.125,28.3499188727,28.5708182758,28.466838708146,3,2,272,283,sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,Unmodified
LN(N-Glycosylation)DTVTVR{Fuc:1; Hex:5; HexNAc:4},2685.1255912431993,4.364651887640685e-06,11.0419796033,54.0107734762,0,33676266.25,27.7964908427,28.1117599593,27.887145072842,3,1,1190,1198,sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3,Unmodified
SRLQN(N-Glycosylation)FSR{Fuc:1; Hex:8; HexNAc:4; Neu5Ac:1},3552.422212022339,5.678055620556035e-07,12.2631133614,9.78735732736,0,122441501.25,34.8367993063,35.6678862081,35.259573223813,3,3,3822,3830,sp|Q63HN8|RN213_HUMAN E3 ubiquitin-protein ligase RNF213 OS=Homo sapiens OX=9606 GN=RNF213 PE=1 SV=3,Unmodified
M(Oxidation)SN(N-Glycosylation)VTLRK{Fuc:1; Hex:8; HexNAc:5; Neu5Ac:1},3712.508315538285,-4.953375866707659e-06,12.4524765931,38.535679971,0,48093196.875,30.0835700578,30.5308491256,30.276784140491,3,2,0,8,sp|O95171|SCEL_HUMAN Sciellin OS=Homo sapiens OX=9606 GN=SCEL PE=1 SV=2,Unmodified
M(Oxidation)SN(N-Glycosylation)VTLR{Fuc:2; Hex:9; HexNAc:4},3398.3360752,-1.52101879473e-06,0,8.00217686576,0.0296296296296,0,,,,3,1,0,7,sp|O95171|SCEL_HUMAN Sciellin OS=Homo sapiens OX=9606 GN=SCEL PE=1 SV=2,
KN(N-Glycosylation)MTLAGRLAGPLFQTLIVAWIK{Hex:6; HexNAc:5; Neu5Ac:1},4819.312236236491,-7.575937273058642e-06,11.9673670365,17.3637044393,0,126566731.0,90.0270874566,90.5189512915,90.201977943007,5,1,607,630,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,Unmodified
LQVELDN(N-Glycosylation)VTGLLSQSDSKSSKLTK{Fuc:2; Hex:7; HexNAc:4; Neu5Ac:1},5119.32883005,-8.63711613359e-06,0,20.1160720237,0,0,,,,4,1,1277,1301,sp|P35579|MYH9_HUMAN Myosin-9 OS=Homo sapiens OX=9606 GN=MYH9 PE=1 SV=4,
RSFEVEEVETPN(N-Glycosylation)STPPR{Fuc:2; Hex:4; HexNAc:5},3928.67794498,-1.2567982231e-06,0,7.62985325821,0.0304347826087,0,,,,3,1,28,45,sp|Q9UHD8|SEPT9_HUMAN Septin-9 OS=Homo sapiens OX=9606 GN=SEPTIN9 PE=1 SV=2,
NHN(N-Glycosylation)SSRFGK{Hex:6; HexNAc:4},2830.154851424182,-5.328659315222055e-06,10.876405832,15.14552007,0,111269079.9375,46.9140510069,47.6608497407,47.038236191495,2;3,1,155,164,sp|B0I1T2|MYO1G_HUMAN Unconventional myosin-Ig OS=Homo sapiens OX=9606 GN=MYO1G PE=1 SV=2,Unmodified
ENQN(N-Glycosylation)HSYSLK{Hex:6; HexNAc:3; Neu5Ac:1},3091.1926884555046,6.696596583255478e-06,14.8093616751,6.45971686208,0.0364372469636,326522274.0,24.2478185561,24.9707059926,24.42585110925,3,2,941,951,sp|P06756|ITAV_HUMAN Integrin alpha-V OS=Homo sapiens OX=9606 GN=ITGAV PE=1 SV=2,Unmodified
VYKPSAGN(N-Glycosylation)NSLYR{Hex:5; HexNAc:4; Neu5Ac:2},3672.5359892164483,-4.498883481921324e-06,15.1498766357,16.0237991881,0,373337154.625,39.8807550059,40.6426673399,40.26274912618,3,1,154,167,sp|P02749|APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens OX=9606 GN=APOH PE=1 SV=3,Unmodified
VYKPSAGN(N-Glycosylation)NSLYR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3673.53075811,2.47987216373e-06,0,12.1857796672,0,0,,,,3,1,154,167,sp|P02749|APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens OX=9606 GN=APOH PE=1 SV=3,
QDSLVINLN(N-Glycosylation)RSNPK{Fuc:2; Hex:5; HexNAc:5},3714.65691679,-5.85556799661e-06,0,6.22606171285,0.04296875,0,,,,3,1,647,661,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9091682810135,-4.052122623944089e-06,17.0490723036,103.705608102,0,836952329.25,27.826790391,28.5117896225,28.037096475188,2;3,3,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8036834599448,-4.875041001683166e-06,14.6819958244,80.010920848,0,76186686.0,28.5271720078,28.7614793764,28.599620356782,2,1,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:1},2814.1676048166164,-4.567235307785123e-06,12.9489507685,79.0957498827,0,126485166.0625,29.2664419757,30.0106396065,29.490571724002,3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4},2523.0736506472595,-5.673755403888713e-06,11.3656962356,65.4875779231,0,99368651.625,27.8422237263,28.378582806,28.274936623001,3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:1},3179.3038642221495,-5.320797851376603e-06,11.9341455368,46.4471142643,0,94788571.625,28.7465148078,29.4297750062,29.119472673162,3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:3},2482.044470671445,-4.70758203311095e-06,11.9458603766,46.0990927858,0,67812164.375,27.6930034226,27.9019428915,27.811225309594,2;3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
MKLSQGN(N-Glycosylation)TTLSINPVKR{Fuc:1; Hex:5; HexNAc:4},3654.66786172,3.39851534237e-06,0,8.55922224404,0.0144230769231,0,,,,3,1,371,388,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,
LPQKN(N-Glycosylation)SSEGNK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3551.4306892364116,2.681817318689874e-06,11.9066530048,13.2295866248,0,152926675.5,67.1507351226,68.1428653743,67.529893472417,3,3,1147,1158,sp|P08575|PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens OX=9606 GN=PTPRC PE=1 SV=3,Unmodified
ISESLRTVN(N-Glycosylation)MTWNK{Hex:5; HexNAc:4; Neu5Ac:2},3882.636783642082,-3.477866291472508e-06,14.3758044223,20.1810733763,0,681004327.625,83.2267813232,84.6851186262,83.796755423768,3,8,2159,2173,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,Unmodified
WLN(N-Glycosylation)RTELEMLSDK{Fuc:1; Hex:8; HexNAc:3},3686.54007411074,-0.00027344565795434534,8.80233867249,9.13298890738,0.00990099009901,36861687.75,78.3782815403,79.2039139893,78.743169508998,3,4,2137,2150,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,Unmodified
TVN(N-Glycosylation)M(Oxidation)TWNK{Fuc:1; Hex:5; HexNAc:3},2574.01803269,4.65305836925e-06,0,8.67607325523,0.0229007633588,0,,,,2,1,2165,2173,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,
IIQRN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:6; Neu5Ac:1},3426.4302451443577,-3.865770534289426e-07,10.8807697927,70.8233058162,0,107254814.125,82.6399668759,83.2426014251,82.924421158059,3,4,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)RTER{Fuc:1; Hex:6; HexNAc:5},3318.432668917743,3.870863925495716e-06,12.5690059368,15.7141339062,0,43185728.75,24.7355535891,24.8529910908,24.794395175203,3;4,1,582,591,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Fuc:3; Hex:6; HexNAc:6},3427.440817084065,2.481318525500096e-06,-20.0931982126,14.1378329674,0,2668394.75,82.7985210922,82.7985210922,82.798521092161,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:6},3135.3397105721924,-1.979534655102472e-06,12.9265976284,12.9595724995,0,79852741.5,78.3461169587,78.7115740405,78.521208674335,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
VN(N-Glycosylation)GSEQTVVAFFIM(Oxidation)PAR{Fuc:1; Hex:6; HexNAc:3; Neu5Ac:1},3899.671907673341,-4.629899783582403e-06,-7.15574413115,7.16126519605,0.0304347826087,7378408.375,83.8758296913,84.32061924,83.875829691315,3,1,354,371,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IMLKGDN(N-Glycosylation)ITLLQSVSN{Fuc:1; Hex:8; HexNAc:4},4000.77861514,-0.000260276360339,0,6.20732798412,0.04296875,0,,,,3,1,76,92,sp|P62304|RUXE_HUMAN Small nuclear ribonucleoprotein E OS=Homo sapiens OX=9606 GN=SNRPE PE=1 SV=1,
ADLRDN(N-Glycosylation)YSPGWK{Fuc:1; Hex:6; HexNAc:3},3148.3188918533515,-1.029043052962263e-05,12.2723929355,13.452008149,0,56682580.125,43.1397865242,43.5244683729,43.36909720761,3,1,1342,1354,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,Unmodified
VEATKN(N-Glycosylation)ETSAPFK{Fuc:4; Hex:6; HexNAc:5},3992.64141451,5.96915832545e-06,0,7.07982395218,0.0325203252033,0,,,,3,1,720,733,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,
KN(N-Glycosylation)LTLSK{Fuc:1; Hex:6; HexNAc:6},3139.3436776659623,-4.2692337004478666e-07,14.0002197907,38.8256638241,0,120996488.25,28.8508677747,29.1928363747,28.99966728948,3,2,924,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
IARLYLVSDVLYN(N-Glycosylation)SSAK{Hex:8; HexNAc:3},3817.6960167107713,-0.0002589910332863601,-6.18562497859,6.01989645836,0.05,10854394.25,69.2785107917,69.5608234074,69.278510791683,4,1,591,608,sp|O15042|SR140_HUMAN U2 snRNP-associated SURP motif-containing protein OS=Homo sapiens OX=9606 GN=U2SURP PE=1 SV=2,Unmodified
YTGTRPSNLAN(N-Glycosylation)NTILVK{Fuc:1; Hex:3; HexNAc:5},3508.6338610435737,-4.234926439281416e-06,-4.26366203425,12.0296348498,0,6620983.0,50.0427749739,50.0895997749,50.089599774901,3,2,335,352,sp|P19224|UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens OX=9606 GN=UGT1A6 PE=1 SV=2,Unmodified
LPTSALVN(N-Glycosylation)LSHGSR{Fuc:3; Hex:5; HexNAc:5; Neu5Ac:1},4005.7239058402574,-1.1377120352192761e-06,-5.99639277843,8.87768841091,0.00990099009901,7541018.0,57.8808877574,58.0662454234,57.971761574968,3;4,1,1163,1177,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:3; Hex:6; HexNAc:5; Neu5Ac:1},3969.71704012,-4.06468984243e-06,0,12.504153434,0,0,,,,3,1,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3582.6042444134328,-5.177357641856638e-06,11.9592382731,9.66505188681,0,16921020.0,47.2403184758,47.366044659,47.271913872782,3,2,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
LERN(N-Glycosylation)FTVSAVIFK{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3420.551729066059,-5.512705575840167e-06,-3.92504684416,7.35010866563,0.0304347826087,5770712.125,47.6452222413,47.7225095258,47.707106509431,3,1,151,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
TERLERN(N-Glycosylation)FTVSAVIFK{Hex:5; HexNAc:2},3125.447262808572,5.677720804815158e-06,8.66115685165,6.88850644609,0.0325203252033,18773648.0,75.9903136915,76.1491521067,76.038342526182,3,1,148,164,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
LILDN(N-Glycosylation)DTIK{Fuc:1; Hex:8; HexNAc:7},3907.616311349363,1.552864225478978e-06,12.0992579066,36.1196489393,0,85175614.125,72.5308378087,72.8777430918,72.719519109154,3,3,405,414,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,Unmodified
N(N-Glycosylation)STIVFPLPIDM(Oxidation)LQGIIGAK{Fuc:2; Hex:6; HexNAc:7; Neu5Ac:1},5119.28419689,-4.79589999813e-06,0,29.7326930052,0,0,,,,4,1,263,283,sp|P27105|STOM_HUMAN Stomatin OS=Homo sapiens OX=9606 GN=STOM PE=1 SV=3,
INLELRN(N-Glycosylation)R{Fuc:2; Hex:8; HexNAc:5},3630.53739328,-2.39609258306e-06,0,20.4317508948,0,0,,,,3,2,6,14,sp|Q9BTT0|AN32E_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member E OS=Homo sapiens OX=9606 GN=ANP32E PE=1 SV=1,
IHYLYLQNNFITELPVESFQN(N-Glycosylation)ATGLR{Fuc:4; Hex:8; HexNAc:7},6381.78582857,1.13142612349e-07,0,16.2824657077,0,0,,,,5,1,103,129,sp|P51888|PRELP_HUMAN Prolargin OS=Homo sapiens OX=9606 GN=PRELP PE=1 SV=1,
GRN(N-Glycosylation)WSRER{Hex:5; HexNAc:2},2275.9511724459126,1.7193004685735559e-06,15.9033024224,77.7627842347,0,334062164.625,63.6876621908,64.2057520416,63.923675476138,2;3,2,2119,2127,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
GRN(N-Glycosylation)WSRER{Fuc:1; Hex:6; HexNAc:6; Neu5Ac:1},3687.509918936582,-8.459541936870952e-06,13.3642707651,62.2500142289,0,127549111.875,62.6284705744,63.404465674,63.009515959644,3,2,2119,2127,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
ERGRN(N-Glycosylation)WSR{Hex:6; HexNAc:2},2438.0106060396024,-1.106283650115905e-06,14.1093708199,60.0839967787,0,61406881.6875,63.3888522929,63.7660095559,63.62406912508,2,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
GRN(N-Glycosylation)WSRER{Fuc:3; Hex:6; HexNAc:6},3688.5106123,-3.11424249726e-06,0,12.372802315,0,0,,,,3,2,2119,2127,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,
VNN(N-Glycosylation)C(Carbamidomethyl)SDM(Oxidation)C(Carbamidomethyl)FHQK{Hex:9; HexNAc:4},3825.41608405,-5.70252345635e-06,0,9.58927614729,0.00990099009901,0,,,,3,1,728,740,sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,
VNN(N-Glycosylation)C(Carbamidomethyl)SDM(Oxidation)C(Carbamidomethyl)FHQK{Hex:8; HexNAc:4},3664.3796693073286,-0.0002833285016245707,8.97032801716,7.2947409809,0.0304347826087,25370417.0,61.3420322563,61.8274979061,61.827497906113,3,3,728,740,sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,Unmodified
LQMWVDLFPKALGRPGPPFN(N-Glycosylation)ITPRR{Hex:4; HexNAc:5; Neu5Ac:1},4860.336442035039,-8.79076375249797e-06,-1.57273564934,26.9632858436,0,76747918,96.2572041895,96.288711173,96.273520408694,4,2,1782,1807,sp|O75923|DYSF_HUMAN Dysferlin OS=Homo sapiens OX=9606 GN=DYSF PE=1 SV=1,Unmodified
DGKN(N-Glycosylation)ATTDALTSVLTKINR{Fuc:1; Hex:7; HexNAc:6; Neu5Ac:1},4807.112064013988,-6.731189967456756e-06,10.1306108794,25.8199240734,0,42096576.25,80.9301539407,81.0731797244,80.994080709044,3;4,1,4144,4163,sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens OX=9606 GN=ANK3 PE=1 SV=3,Unmodified
KKSDAN(N-Glycosylation)ASYLR{Fuc:2; Hex:6; HexNAc:6},3734.56555636,1.56900220633e-07,0,9.10525544377,0.00990099009901,0,,,,3,1,36,47,sp|Q12955|ANK3_HUMAN Ankyrin-3 OS=Homo sapiens OX=9606 GN=ANK3 PE=1 SV=3,
LN(N-Glycosylation)LTTDPK{Hex:4; HexNAc:5},2564.0962889569214,1.3705480731720924e-06,13.4292980848,56.3750034646,0,81878975.0,28.3202690588,28.5271720078,28.408261540159,2;3,4,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
LN(N-Glycosylation)LTTDPK{Hex:7; HexNAc:7},3456.41768186254,-1.9193104861376557e-07,15.5257331695,39.0562285836,0,105871437.0,27.2798492577,27.5290992246,27.382611289247,3,2,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
LN(N-Glycosylation)LTTDPK{Hex:7; HexNAc:6; Neu5Ac:1},3544.431594072031,4.1427900622410927e-07,13.6101992537,38.9109837785,0,164711671.375,28.4378240254,29.0141978568,28.599620356782,3,2,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
N(N-Glycosylation)VTVKSEGAIQVNFTLVR{Fuc:2; Hex:4; HexNAc:4},3726.728009810771,1.7216447087115758e-06,-21.3169254967,7.85902932825,0.0304347826087,3526996.75,79.5373522069,79.5531197892,79.53735220693,3,1,854,872,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,Unmodified
VKIYTFN(N-Glycosylation)QSR{Hex:3; HexNAc:2},2146.9785925231345,4.980789041421253e-06,12.7165271759,8.09423109551,0.0188679245283,32205791.875,53.972801676,54.2034218576,54.156697442754,2,1,182,192,sp|Q16851|UGPA_HUMAN UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=UGP2 PE=1 SV=5,Unmodified
SLLKVYNKDPAHAFN(N-Glycosylation)HTPK{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:2},4823.12535133,-0.000212593054633,0,11.891859741,0,0,,,,4,1,256,275,sp|Q5T5P2|SKT_HUMAN Sickle tail protein homolog OS=Homo sapiens OX=9606 GN=KIAA1217 PE=1 SV=2,
QYRQAN(N-Glycosylation)GSAKK{Hex:5; HexNAc:4; Neu5Ac:1},3163.308815417138,6.619863852717338e-06,7.93085261348,8.47460976804,0.0144230769231,13984730.125,39.7582152591,40.1566790408,39.987813809141,3,2,1774,1785,sp|Q5T5P2|SKT_HUMAN Sickle tail protein homolog OS=Homo sapiens OX=9606 GN=KIAA1217 PE=1 SV=2,Unmodified
N(N-Glycosylation)LTFNITKTIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6868972781526,-5.431756254707657e-06,12.1090730606,12.0765913728,0,100178728.25,49.6854801403,50.0271925595,49.808684574191,3;4,3,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
NLTFN(N-Glycosylation)ITKTIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6868972781526,-5.431756254707657e-06,12.1090730606,12.0765913728,0,100178728.25,49.6854801403,50.0271925595,49.808684574191,3;4,3,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
KLSPFN(N-Glycosylation)ITHR{Fuc:3; Hex:6; HexNAc:5},3637.56567556,-1.80187715749e-07,0,21.7947955682,0,0,,,,3,1,568,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",
EN(N-Glycosylation)RSLETK{Hex:4; HexNAc:2},2029.8571395583149,5.627165908464237e-06,12.0655179377,12.8248036807,0,25312489.0,29.1487213916,29.3555805391,29.207355025037,2,1,252,260,sp|Q8IYM0|F186B_HUMAN Protein FAM186B OS=Homo sapiens OX=9606 GN=FAM186B PE=2 SV=2,Unmodified
GSKSSQQEFQEVFN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3975.60969436,4.13079830064e-06,0,8.10714703368,0.0188679245283,0,,,,3,1,605,620,sp|Q9BVQ7|AFG2B_HUMAN ATPase family gene 2 protein homolog B OS=Homo sapiens OX=9606 GN=AFG2B PE=1 SV=2,
ETN(N-Glycosylation)LSTK{Fuc:1; Hex:4; HexNAc:5},2601.070357434121,-6.900307774553014e-07,13.0436263402,79.2610679604,0,358010616.4375,40.4621698922,41.1298026429,40.85604147377,2;3,3,1678,1685,sp|Q92817|EVPL_HUMAN Envoplakin OS=Homo sapiens OX=9606 GN=EVPL PE=1 SV=3,Unmodified
ETN(N-Glycosylation)LSTK{Fuc:1; Hex:5; HexNAc:5},2763.1210826723186,1.0978950678148148e-07,14.1878303536,58.5183239703,0,189215111.75,40.0488300429,40.8251601404,40.52133817536,3,2,1678,1685,sp|Q92817|EVPL_HUMAN Envoplakin OS=Homo sapiens OX=9606 GN=EVPL PE=1 SV=3,Unmodified
ETN(N-Glycosylation)LSTK{Fuc:1; Hex:6; HexNAc:5},2925.171113060092,1.0585337773759403e-06,11.6498891127,39.0362088039,0,18685363.25,39.9878138091,40.172028274,40.048830042903,3,2,1678,1685,sp|Q92817|EVPL_HUMAN Envoplakin OS=Homo sapiens OX=9606 GN=EVPL PE=1 SV=3,Unmodified
VQPRVN(N-Glycosylation)VSPSK{Fuc:3; Hex:5; HexNAc:4},3270.44287576,-1.39806123313e-06,0,8.77565564499,0.00990099009901,0,,,,3,1,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",
VQPRVN(N-Glycosylation)VSPSK{Fuc:2; Hex:6; HexNAc:6},3692.5807288,3.04240854957e-06,0,8.44510797989,0.0144230769231,0,,,,3,1,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",
VQPRVN(N-Glycosylation)VSPSK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3269.441309160469,-7.15925730893006e-06,12.5173198681,8.02803055174,0.0276497695853,128382017.5,38.3117198732,38.6795104569,38.450743991756,3,3,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",Unmodified
VQPRVN(N-Glycosylation)VSPSK{Fuc:3; Hex:7; HexNAc:6},4000.68116446,5.38180768094e-06,0,7.29456493606,0.0304347826087,0,,,,3,1,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",
VM(Oxidation)VTN(N-Glycosylation)VTSLLK{Fuc:4; Hex:6; HexNAc:5},3791.612698886101,4.575758585195055e-06,8.89363844964,11.1417835085,0,23549874.25,53.3006338424,53.4095783737,53.347435107454,3,1,2119,2130,sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3,Unmodified
QEDVIATAN(N-Glycosylation)LSRR{Fuc:4; Hex:6; HexNAc:5},4043.74121125,-5.30915451531e-06,0,6.56213776698,0.0325203252033,0,,,,3,1,2197,2210,sp|Q9Y490|TLN1_HUMAN Talin-1 OS=Homo sapiens OX=9606 GN=TLN1 PE=1 SV=3,
N(N-Glycosylation)C(Carbamidomethyl)TSFR{Fuc:1; Hex:8; HexNAc:7},3647.3784978519748,-2.4733790721033293e-06,4.19889544992,47.1433876572,0,14637516.125,64.3950265593,64.6773461408,64.410814407094,3,2,633,639,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,Unmodified
KLPPGLLAN(N-Glycosylation)FTLLR{Fuc:1; Hex:9; HexNAc:4},3968.7816222391216,4.855655629890481e-06,-3.87076579652,10.7329459214,0,12507615.375,41.527206356,41.662931723,41.542310089493,3,1,177,191,sp|P02750|A2GL_HUMAN Leucine-rich alpha-2-glycoprotein OS=Homo sapiens OX=9606 GN=LRG1 PE=1 SV=2,Unmodified
QAVTNPN(N-Glycosylation)NTFYATKRLIGR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:2},4806.10326997,-4.61696729303e-07,0,6.71165225978,0.0325203252033,0,,,,4,1,107,126,"sp|P38646|GRP75_HUMAN Stress-70 protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPA9 PE=1 SV=2",
LINRN(N-Glycosylation)TTIPTKK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3660.663172791962,-3.6660006176097783e-06,10.9328776174,6.24501361793,0.04296875,11623547.625,78.6791052924,78.8867223726,78.822902356211,3,1,456,468,"sp|P38646|GRP75_HUMAN Stress-70 protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPA9 PE=1 SV=2",Unmodified
N(N-Glycosylation)DSLRK{Fuc:1; Hex:4; HexNAc:3},2134.8944542778318,2.560932835393924e-06,16.316704699,38.9836751041,0,361314124.25,24.9707059926,25.3116960234,25.161063459142,2;3,2,187,193,sp|Q15631|TSN_HUMAN Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,Unmodified
GFFNLN(N-Glycosylation)RSSKR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3675.550543285393,-5.489611239378437e-06,16.6255777781,21.8722758199,0,393861419.5625,30.97855809,31.6798383262,31.217943392817,3;4,4,43,54,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
RGFFNLN(N-Glycosylation)RSSK{Fuc:2; Hex:7; HexNAc:6},3969.67726066,-3.88622420329e-06,0,8.37665894373,0.0144230769231,0,,,,3,1,42,53,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,
SYPSKLARN(N-Glycosylation)ESR{Hex:4; HexNAc:3},2664.1960348496773,-7.506199553493746e-06,12.8251842437,10.4418156885,0.00574712643678,14490954.9375,59.8040342238,60.0079800751,59.882658039157,3,2,473,485,sp|O43516|WIPF1_HUMAN WAS/WASL-interacting protein family member 1 OS=Homo sapiens OX=9606 GN=WIPF1 PE=1 SV=3,Unmodified
FEVFKN(N-Glycosylation)GTLR{Fuc:2; Hex:6; HexNAc:6},3692.58065059,-5.70067664105e-06,0,8.68457674987,0.00990099009901,0,,,,3,1,457,467,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,
KN(N-Glycosylation)RTFLRPPK{Hex:10; HexNAc:2},3282.4589541269283,-6.291212449868941e-06,-4.23615526158,9.49990901861,0.00990099009901,10591480.375,84.3528875258,84.4642432398,84.464243239784,3,2,236,246,sp|O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,Unmodified
N(N-Glycosylation)ITLDDASAPRLM(Oxidation)VLR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},4005.76791499,-4.66963389984e-06,0,8.99580918599,0.00990099009901,0,,,,3,1,758,774,sp|O75534|CSDE1_HUMAN Cold shock domain-containing protein E1 OS=Homo sapiens OX=9606 GN=CSDE1 PE=1 SV=2,
REN(N-Glycosylation)ISHNTQDILIPNVLLSQEK{Fuc:1; Hex:7; HexNAc:7},5262.39190048,-9.06547900722e-06,0,13.3944379792,0,0,,,,6,1,1104,1126,sp|Q12802|AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens OX=9606 GN=AKAP13 PE=1 SV=2,
LLAKILN(N-Glycosylation)M(Oxidation)SSGR{Hex:8; HexNAc:4},3427.524812630574,-0.0003036823841299439,15.6024989574,9.90015277101,0.00990099009901,595977331.0,69.1683477905,69.5294103092,69.309878141308,3;4,2,238,250,"sp|P31937|3HIDH_HUMAN 3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=HIBADH PE=1 SV=2",Unmodified
N(N-Glycosylation)VTVKTIK{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3326.445358040601,-5.580351357990156e-06,10.398402593,10.5707967758,0.015625,41532987.125,70.8870448576,71.1704370564,71.060426241779,3,1,258,266,sp|Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 OS=Homo sapiens OX=9606 GN=NAP1L4 PE=1 SV=1,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3968.709060093683,-5.04160980068257e-06,13.8722312817,25.7136158655,0,550553029.75,88.9927048073,90.2967087732,89.595896759256,3,5,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3677.6035194183355,-2.6877594508555067e-06,13.8680632383,25.0007017768,0,339552642.0,84.225036576,85.0482778257,84.700652423127,3,4,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:2; Hex:6; HexNAc:4; Neu5Ac:1},3985.736875141093,-8.156087557093165e-06,12.6586376897,13.7270524853,0,195138005.75,89.2780610071,90.0106275227,89.516279239082,3,2,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3969.71791978,-2.13296694161e-06,0,10.3468336405,0.00574712643678,0,,,,3,1,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,
VKDLM(Oxidation)VIN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:2},3818.596543633786,-4.486945310971816e-06,10.9537102291,53.4535934071,0,25939323.25,40.0488300429,40.3554353263,40.293517492835,3,2,221,230,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
TVN(N-Glycosylation)VSVPKKTR{Fuc:2; Hex:7; HexNAc:5},3669.6066516993897,1.556714774247631e-06,-21.2879444595,12.6469617631,0,1491532,76.9930796252,76.9930796252,76.993079625193,3,3,88,99,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
TN(N-Glycosylation)KSHK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},2773.1382540141935,-7.675295035590341e-06,11.1643244999,55.8549125881,0,64636580.0,29.2367072092,29.6537499573,29.399677175903,3,2,320,326,sp|Q15717|ELAV1_HUMAN ELAV-like protein 1 OS=Homo sapiens OX=9606 GN=ELAVL1 PE=1 SV=2,Unmodified
ADLVN(N-Glycosylation)R{Hex:9; HexNAc:4},2957.158860864756,1.7509464750122343e-06,13.0295499072,63.4652638022,0,62715811.25,25.9212820596,26.3051235424,26.038461572552,3,2,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
ADLVN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:5},2804.1552051570593,-2.5925890323305974e-06,12.9349409795,63.3056894673,0,59920479.125,40.7480580753,41.1913906084,40.947569825872,3,1,374,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,Unmodified
KMAN(N-Glycosylation)SSPVLSK{Fuc:1; Hex:4; HexNAc:4},2767.2315660137638,-8.141588416629065e-06,11.3971319129,17.1278948126,0,41455717.125,39.3383750584,39.6487896429,39.416422139231,3,2,212,223,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,Unmodified
DN(N-Glycosylation)TTLLTQVQTTMR{Hex:6; HexNAc:3},3202.387805286799,-5.816569785318082e-06,13.1672973929,13.774207618,0,50073436.0,59.8513155248,60.0699716236,59.945807606602,3,1,365,379,sp|Q13561|DCTN2_HUMAN Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4,Unmodified
ALKN(N-Glycosylation)YTK{Fuc:5; Hex:8; HexNAc:7},4284.75586657,-2.92307780681e-06,0,10.9811685132,0.00847457627119,0,,,,3,1,245,252,sp|Q96MW7|TIGD1_HUMAN Tigger transposable element-derived protein 1 OS=Homo sapiens OX=9606 GN=TIGD1 PE=1 SV=1,
SVKEDSN(N-Glycosylation)LTLQEKK{Fuc:2; Hex:6; HexNAc:4},3694.629409047417,-5.899331703864738e-06,14.1665557184,53.1237270438,0,248079316.125,84.3687349902,85.0482778257,84.637739474201,3,3,1442,1456,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,Unmodified
MTNAKN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:6; Neu5Ac:2},3590.40069991,1.71704552086e-06,0,8.07359045755,0.0296296296296,0,,,,3,1,269,276,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,
QDKMTNAKN(N-Glycosylation)R{Hex:5; HexNAc:2},2421.00903879,4.98868763669e-06,0,6.58621518625,0.0325203252033,0,,,,2,1,266,276,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,
LN(N-Glycosylation)LTGAVR{Fuc:1; Hex:5; HexNAc:6; Neu5Ac:1},3308.4042148751073,-3.9706063421020515e-06,-20.7979268969,8.62052858746,0.0229007633588,3328263.875,54.805797357,54.8688114749,54.868811474864,3,1,982,990,sp|Q5DID0|UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens OX=9606 GN=UMODL1 PE=2 SV=2,Unmodified
LKN(N-Glycosylation)ISPK{Fuc:2; Hex:7; HexNAc:6},3443.4554636982753,7.815714222884066e-07,10.177947282,52.3072594438,0,79102665.125,82.7345644421,83.2109826233,82.924421158059,3,2,615,622,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
LNAEN(N-Glycosylation)HSHIK{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:2},3804.55705555,-5.7350805839e-06,0,6.64767390521,0.0325203252033,0,,,,3,1,1156,1166,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3718.54369921,-3.93370157421e-07,0,10.5896667074,0,0,,,,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
N(N-Glycosylation)ASGTKAVSVM(Oxidation)VK{Hex:5; HexNAc:4},2929.282760928717,-3.300257170878593e-06,11.1926195615,14.2551138099,0,32127362.0,39.0954867906,39.3080750571,39.216410905743,3,2,30050,30063,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,Unmodified
AN(N-Glycosylation)KTPIRM(Oxidation)R{Fuc:4; Hex:8; HexNAc:8},4606.88043517,3.57393870105e-06,0,13.7565089364,0,0,,,,3,1,21151,21160,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
VHTN(N-Glycosylation)ATIR{Hex:5; HexNAc:4; Neu5Ac:1},2824.16633457,3.24085792951e-06,0,12.4272212902,0,0,,,,3,1,30317,30325,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
YTIEAEN(N-Glycosylation)QSGKK{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3718.53394756,-2.7803334072e-06,0,10.7279545229,0,0,,,,3,1,30441,30453,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
LRAELDEVN(N-Glycosylation)KSAK{Fuc:4; Hex:6; HexNAc:5},4043.75166259,-1.67371015688e-06,0,7.22477530853,0.0304347826087,0,,,,3,1,123,136,sp|Q03252|LMNB2_HUMAN Lamin-B2 OS=Homo sapiens OX=9606 GN=LMNB2 PE=1 SV=4,
NVLLN(N-Glycosylation)NSEKM(Oxidation)K{Hex:8; HexNAc:7; Neu5Ac:2},4604.85497428633,-2.195504804289565e-06,-4.88681925744,22.9520199769,0,23890831.5,88.2340383079,88.3766116566,88.313391322517,3,1,568,579,sp|Q08J23|NSUN2_HUMAN RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,Unmodified
